NFG
IONS icon

Next Financial Group’s Ionis Pharmaceuticals IONS Stock Holding History

Next Financial Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$88K Buy
2,893
+1,628
+129% +$51.2K 0.01% 1230
2021
Q3 		$43K Buy
1,265
+18
+1% +$678 ﹤0.01% 1472
2021
Q2 		$50K Sell
1,247
-1,570
-56% -$61.5K ﹤0.01% 1381
2021
Q1 		$127K Sell
2,817
-12
-0.4% -$669 0.01% 926
2020
Q4 		$160K Buy
2,829
+178
+7% +$8.87K 0.02% 795
2020
Q3 		$126K Buy
+2,651
New +$147K 0.01% 768
2020
Q2 		– Sell
-1,604
Closed -$76K – 1216
2020
Q1 		$76K Buy
1,604
+193
+14% +$10.8K 0.01% 849
2019
Q4 		$86K Buy
1,411
+30
+2% +$1.79K 0.01% 1002
2019
Q3 		$83K Buy
1,381
+72
+6% +$4.69K 0.01% 971
2019
Q2 		$84K Buy
1,309
+1,045
+396% +$73.9K 0.01% 974
2019
Q1 		$21K Buy
+264
New +$17K 0.01% 954
2018
Q4 		– Sell
-14
Closed -$1K – 2017
2018
Q3 		$1K Buy
+14
New +$658 ﹤0.01% 1396
2017
Q4 		– Sell
-11
Closed -$1K – 805
2017
Q3 		$1K Buy
+11
New +$576 ﹤0.01% 1688
2016
Q1 		– Sell
-1,516
Closed -$93K – 1792
2015
Q4 		$93K Hold
1,516
– – 0.03% 441
2015
Q3 		$61K Buy
1,516
+976
+181% +$50.5K 0.02% 571
2015
Q2 		$31K Hold
540
– – 0.01% 834
2015
Q1 		$34K Buy
+540
New +$36.6K 0.01% 793
2014
Q4 		– Sell
-110
Closed -$4K – 2114
2014
Q3 		$4K Buy
+110
New +$3.9K ﹤0.01% 2144

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Next Financial Group's IONS Position: Q4 2021 in Review

Next Financial Group increased its Ionis Pharmaceuticals (IONS) stake by 129% in Q4 2021, buying an estimated $51.2K and bringing the position to 2,893 shares worth $88K. The position accounts for 0.01% of the portfolio, ranked #1230.

Next Financial Group first reported a position in IONS in Q3 2014 and has held it in 18 quarters since. The position peaked at $160K in Q4 2020. 340 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

  • Next Financial Group held 2,893 shares of Ionis Pharmaceuticals worth $88K as of Q4 2021.
  • Next Financial Group bought 1,628 Ionis Pharmaceuticals shares in Q4 2021, an estimated $51.2K.
  • Ionis Pharmaceuticals made up 0.01% of Next Financial Group's portfolio in Q4 2021, its #1230 holding.
  • Next Financial Group first reported a position in Ionis Pharmaceuticals in Q3 2014 and has held it in 18 quarters since.
  • Next Financial Group's Ionis Pharmaceuticals position peaked at $160K in Q4 2020.
  • 340 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.